(NASDAQ: WGS) Genedx Holdings's forecast annual revenue growth rate of 12.01% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.23%.
Genedx Holdings's revenue in 2024 is $202,566,000.On average, 1 Wall Street analysts forecast WGS's revenue for 2024 to be $5,911,550,722, with the lowest WGS revenue forecast at $5,911,550,722, and the highest WGS revenue forecast at $5,911,550,722.
In 2025, WGS is forecast to generate $6,740,053,644 in revenue, with the lowest revenue forecast at $6,740,053,644 and the highest revenue forecast at $6,740,053,644.